Falagario, Ugo G. http://orcid.org/0000-0002-1152-3005
Lantz, Anna
Jambor, Ivan
Busetto, Gian Maria
Bettocchi, Carlo
Finati, Marco
Ricapito, Anna
Luzzago, Stefano
Ferro, Matteo
Musi, Gennaro
Totaro, Angelo
Racioppi, Marco
Carbonara, Umberto
Checcucci, Enrico
Manfredi, Matteo
D’Aietti, Damiano
Porcaro, Antonio Benito
Nordström, Tobias
Björnebo, Lars
Oderda, Marco
Soria, Francesco
Taimen, Pekka
Aronen, Hannu J.
Perez, Ileana Montoya
Ettala, Otto
Marchioni, Michele
Simone, Giuseppe
Ferriero, Mariaconsiglia
Brassetti, Aldo
Napolitano, Luigi
Carmignani, Luca
Signorini, Claudia
Conti, Andrea
Ludovico, Giuseppe
Scarcia, Marcello
Trombetta, Carlo
Claps, Francesco
Traunero, Fabio
Montanari, Emanuele
Boeri, Luca
Maggi, Martina
Del Giudice, Francesco
Bove, Pierluigi
Forte, Valerio
Ficarra, Vincenzo
Rossanese, Marta
Mucciardi, Giuseppe
Pagliarulo, Vincenzo
Tafuri, Alessandro
Mirone, Vincenzo
Schips, Luigi
Antonelli, Alessandro
Gontero, Paolo
Cormio, Luigi
Sciarra, Alessandro
Porpiglia, Francesco
Bassi, PierFrancesco
Ditonno, Pasquale
Boström, Peter J.
Messina, Emanuele
Panebianco, Valeria
De Cobelli, Ottavio
Carrieri, Giuseppe
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
https://doi.org/10.1007/s00345-023-04634-2
Funding for this research was provided by:
Università di Foggia
Article History
Received: 27 June 2023
Accepted: 14 September 2023
First Online: 3 October 2023
Declarations
:
: The authors declare no conflict of interest related to the present study.
: The present study was approved by University of Foggia ethical committee with a waiver on consent to participate.